Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heiss

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systemsH Allgayer, R Babic, K U Gruetzner, et al.
The Journal of Biological Chemistry|February 13, 1999
Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factorH Allgayer, H Wang, Y Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 17, 2009
Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosisMichael A Ströhlein, Robert Siegel, Michael Jäger, et al.
Annals of Surgery|December 31, 1997
Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancerM M Heiss, H Allgayer, K U Gruetzner, et al.
Zentralblatt Fur Chirurgie|June 21, 2005
[Laparoscopic incisional hernia repair -- an alternative to the conventional procedure?]M K Angele, F Löhe, J Dietz, et al.
American Journal of Health Behavior|November 27, 2001
Sources of HIV-prevention information for individuals at high riskL M Sagrestano, R M Heiss-Wendt, A N Mizan, et al.
Cancer Research|April 1, 1997
Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor diseaseH Allgayer, M M Heiss, R Riesenberg, et al.
Cancer|March 20, 2002
Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosisHeike Aligayer, Douglas D Boyd, Markus M Heiss, et al.
Life (Basel, Switzerland)|July 27, 2024
VacStent as an Innovative Approach in the Treatment of Anastomotic Insufficiencies and Leakages in the Gastrointestinal Tract-Review and OutlookAlexander Yohannes, Judith Knievel, Jonas Lange, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1991
Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane protein I by C1q binding assayA Eckhardt, M M Heiss, W Ehret, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systemsH Allgayer, R Babic, K U Gruetzner, et al.
The Journal of Biological Chemistry|February 13, 1999
Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factorH Allgayer, H Wang, Y Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 17, 2009
Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosisMichael A Ströhlein, Robert Siegel, Michael Jäger, et al.
Annals of Surgery|December 31, 1997
Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancerM M Heiss, H Allgayer, K U Gruetzner, et al.
Zentralblatt Fur Chirurgie|June 21, 2005
[Laparoscopic incisional hernia repair -- an alternative to the conventional procedure?]M K Angele, F Löhe, J Dietz, et al.
American Journal of Health Behavior|November 27, 2001
Sources of HIV-prevention information for individuals at high riskL M Sagrestano, R M Heiss-Wendt, A N Mizan, et al.
Cancer Research|April 1, 1997
Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor diseaseH Allgayer, M M Heiss, R Riesenberg, et al.
Cancer|March 20, 2002
Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosisHeike Aligayer, Douglas D Boyd, Markus M Heiss, et al.
Life (Basel, Switzerland)|July 27, 2024
VacStent as an Innovative Approach in the Treatment of Anastomotic Insufficiencies and Leakages in the Gastrointestinal Tract-Review and OutlookAlexander Yohannes, Judith Knievel, Jonas Lange, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1991
Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane protein I by C1q binding assayA Eckhardt, M M Heiss, W Ehret, et al.
Pageof 13